Development of an Alendronate Controlled Delivery System for Bone Repair Applications
نویسندگان
چکیده
Extended Abstract A great interest has been shown towards designing bone targeted medical delivery systems for the treatment of several bone disorders. This approach ensures the release of the drug to the site of the disease [1]. Moreover, it allows delivery of drugs that have low bioavailability when administrated by conventional routes. This leads to enhanced patient adherence and an improved clinical outcome of bone related diseases [2]. Given that hydroxyapatite is a major component of the bone matrix, it represents a target for specific delivery systems [3]. Due to their structure which consists in two phosphonates groups linked to a carbon atom, bisphosphonates show a high affinity for hydroxyapatite. Furthermore they increase both osteoblast proliferation and osteoclast apoptosis leading to bone remodeling [4]. Alendronate is a bisphosphonate used in the treatment and prevention of osteoporosis, Paget's disease, primary hyperparathyroidism, bone metastasis, multiple myeloma [5]. Microparticle-mediated drug delivery to the bone is a promising approach which ensures a high local alendronate concentration and a controlled release of the drug [4, 6]. A recent study conducted by Stadelmann et al. [7] shows an increase in bone density when zoledronate was locally delivered. Poly lactic-co-glycolic acid (PLGA) is a copolymer approved to be safe in pharmaceutical applications by the FDA due to its biocompatibility and biodegradability. A number of PLGA compounds with different copolymer ratio are used to design microparticles with various properties [8]. The aim of the study is to develop and optimize a PLGA-alendronate microparticles based delivery device, designed to target the bone tissue. This carrier system has the advantages of a high biocompatibility and a controlled release of the incorporated drug. Furthermore, it has the benefit of being a biodegradable system [8, 9]. In a first step, the microencapsulation process is to be optimized. There are a number of techniques for PLGA microparticles preparation such as supercritical fluid extraction, extrusion and spray drying [6]. However, the method optimized for this study is the solvent evaporation method. Using this method the microparticles are prepared via a water/oil/water (w/o/w) double emulsion. Initially we prepared two solutions: the alendronate aqueous solution and the PLGA organic solution. The solutions were used to form the primary emulsion which was poured into a polyvinyl alcohol aqueous solution resulting into the w/o/w double emulsion. In order to evaporate the solvent and form the microparticles, the double emulsion was stirred at room temperature for 4 hours. The microparticles obtained following this method remain to be furthermore characterized in order to evaluate the size distribution, entrapment efficiency, morphology and drug release profile. Also, by altering the manufacturing conditions, copolymer ratio and degradation rate, the microparticles drug loading can be adjusted [1]. In a second step, the optimized alendronate loaded microparticles are to be used to develop an implant with high affinity for bone tissue. In conclusion, this system could improve the local delivery of alendronate and have a high potential in bone repair applications.
منابع مشابه
روش های ژن درمانی برای ترمیم و نوسازی دستگاه عضلانی اسکلتی
Injuries to the musculoskeletal system are common, debilitating and expensive. In many cases, healing is imperfect, which leads to chronic impairment. Gene transfer might improve repair and regeneration at sites of injury by enabling the local, sustained and potentially regulated expression of therapeutic gene products such products include morphogens, growth factors and anti-inflammatory agent...
متن کاملControlling drug delivery kinetics from mesoporous titania thin films by pore size and surface energy
The osseointegration capacity of bone-anchoring implants can be improved by the use of drugs that are administrated by an inbuilt drug delivery system. However, to attain superior control of drug delivery and to have the ability to administer drugs of varying size, including proteins, further material development of drug carriers is needed. Mesoporous materials have shown great potential in dru...
متن کاملPreventing Bone Loss Improves Tendon-Bone Healing in a Canine Model
Studies have shown that tendon insertion site injuries can lead to bone loss. Following tendon-bone repair, bone loss can lead to widening of the repair tunnel. This widening may negatively affect the establishment of a strong tendon-bone interface, leading to recurrence of failure. Our goal was to suppress bone loss after insertion site repair using alendronate in an attempt to prevent the dec...
متن کاملDevelopment of an antibacterial porous scaffold for bone defect treatment
Background & Aim: The use of bone scaffolds is one of the new and efficient techniques for repairing bone defects that provide a suitable platform for cell proliferation and growth to repair the target tissue. One of the most important causes of failure of transplants and surgical procedures is the invasion of bacteria at the site of the complication and the development of severe infection. The...
متن کاملPreparation and biological study of 68Ga-DOTA-alendronate
Objective(s): In line with previous research on the development of conjugated bisphosphonate ligands as new bone-avid agents, in this study, DOTA conjugated alendronate (DOTA-ALN) was synthesized and evaluated after labeling with gallium-68 (68Ga).Methods: DOTA-ALN was synthesized and characterized, followed by 68Ga-DOTA-ALN preparation, using DOTA-ALN and 68GaCl3 (pH: 4-5) at 92-95°C for 10 mi...
متن کامل